Stuart SwansonChairman, Founder,Head of CorporateDevelopmentCo-Founder PharmaSwiss,formerly Head of Marketingat BMS CEE/Israel, GM PfizerRussia and US Diplomat
Barbara KoširNED, Board Member andAudit Committee ChairActing Chair of Ethics andCompliance CommitteeFormerly CFO of PharmaSwiss,prior to that held a series of keyFinance positions at Coca Cola,IBM and AGIP
SWIXX BIOPHARMA BOARD
Petr PípalCFOWorked 3 years as CFO of PharmaSwiss and 10 years in senior finance functions in BMS, Member of the Board in Farma-Projekt Poland.
Jean-Michel LespinasseCEOWorked 6 years as COO ofA&D’s Marketing & SalesDivision. Was as COO at Delta Medical, and before thatwas GM BMS Russia.
Dezső Mártha, MDCOO, Head of Rare Diseases BU and Alliance ManagementHead of Celgene CEE until June 2019, prior to that GM BMS Hungary and BMS CEE Indirect Markets (Balkans + Slovakia + Baltics + Malta + Iceland)
Marcela LaššákováChief Compliance OfficerUntil July 2016 Director Compliance and Internal Controls Valeant /PharmaSwiss EMEA since 2009. Prior to that Business Control Function Manager BMS Austria & Central Europe.
Gabriela ZelenkováLegal Counsel and SecretaryPreviously BMS Vice-President and Ass. General Counsel, Head of Intercontinental R/C Law Department responsible for 65 markets including CEE, Middle East, Africa and India; China, Pacific Rim, Brazil, Latin America; Before that, BMS Vice-President and Ass. General Counsel, Head of R/C Law department Europe supporting all European countries and Distributor Markets of Europe.
Predrag Lukić, MPharmGeneral Manager Serbia, Regional Director Montenegro, North Macedonia, Bosnia and Herzegovina, KosovoFormerly GM PharmaSwiss Serbia. Prior to that held series of BUH and marketing / sales positions in PharmaSwiss Serbia.
Saulius Žemaitis, MDRegional Director Baltic Markets,General Manager LithuaniaUntil Jan, 2015 Regional GM Baltics at Valeant. Until 2011, GM Lithuania at PharmaSwiss and before that GM Lithuania at BMS. Started as BMS Med. Rep.
Davor KovačevićGeneral ManagerCroatia and SloveniaIn Pharma industry as of 2002. Formerly Country manager for Croatia and Slovenia in Celgene. Prior to that held various positions in Alpe-Adria region such as Business unit head, Market access head, Marketing and Sales management in rare diseases, hospital, primary care and OTC area.
Martina BergantGeneral Manager SloveniaFormaly CFO Sanofi for South, East & Central Europe. In pharmaceutical business since 2002, holding different managerial positions covering Slovenia as well as CEE.
Kenan SelmanovićGeneral Manager Bosnia &HerzegovinaFormerly GM PharmaSwiss/Valeant BiH (2011-2018). Prior to that leading Schering Plough BiH (2008-2011), held series roles in GSK (2004-2008)
Ivana PrelevićGeneral Manager MontenegroPreviously GM PharmaSwiss Montenegro 2003-2014 and prior to that GM Pfizer Montenegro.
Žaklina Pop-SimonovaGeneral Manager North Macedonia, Kosovo, AlbaniaFormerly GM PharmaSwiss /Valeant Macedonia, Kosovo, Albania (2012-2016). Prior to that GM PharmaSwiss Macedonia & Kosovo (2005-2012), GM Macedonia PharmaSwiss (2000-2005), GM BMS Macedonia (1996-2000). Started in early 1993 as Ostomy and Wound Care Manager for ConvaTec/BMS.
Gergely KovácsGeneral Manager HungaryEight years of pharma sales & marketing experience as BUD for Pfizer and Krka Hungary. Prior to that, 16 years in different finance/consulting roles including Finance Director for Pfizer Hungary and GM/FD for Tele2.
Gabriela MarkovováGeneral Manager SlovakiaFormer Managing Director at A&D Pharma Marketing & Sales in Slovakia. In the past, BUM onco/orphan, Market Access and Marketing manager onco/orphan at Roche, Celgene and Takeda.
Ivana Pešić, MPharmDirector Corporate RegulatoryAffairs and PharmacovigilancePreviously Head of Regulatory Affairs at PharmaSwiss Serbia and Reg. Manager, KRKA Serbia.
Marija Nikolić, MDRegional Medical Director,Former YugoslaviaClinical Pharmacologist. Held series of positions at leading MNCs / Quintiles in Medical and Research. Prior to that Chief of Clincal Pharmacology at Bel. Hosp.
Jelica ČubrićCorporate Head of QualityAssuranceFormerly QA Associate Director at Valeant Serbia. Previously held series of Quality/Compliance roles at Donau Labs & Coca Cola.
Meta GrosHead of LogisticsFormerly Logistics Coordinator at PharmaSwiss. Prior to that purchase and sales positions in PharmaSwiss.
Ivan Pertot, MPharmRegional BD Director Swixx BrandsPreviously Head of Regulatory Department for non-EU Balkan countries at PharmaSwiss, prior to that Regulatory Affairs Director (2009-2013) and Regulatory Affairs Manager (2007-2009) at PharmaSwiss Serbia and Regulatory Affairs Officer at Schering Plough Serbia.
Alexander AsamBoard ObserverMore than 20 years experiencein the life sciences and privateequity business. Formerly variouspositions at Hoechst, Aventisand Deutsche Bank
Matthias FehrBoard MemberAudit CommiteeFor 17 years investment advisorat HBM Partners. Board observerat PharmaSwiss SA 2007-2011.Formerly Pharma Analyst atLombard Odier
Petr Čapek, MDGeneral Manager Czech RepublicWorked 5 years as GM PharmaSwiss Czech, previously GM Amgen CZ&SK and prior to that worked in various positions at BMS (BUH Oncology/Hospital products & Medical Director) since 1995.
Alexander MarinovGeneral ManagerBulgariaBefore joining Swixx Biopharma served as GM A&D Pharma Marketing and Sales Bulgaria for the last 7 years. Prior to that, BUH Hospital and Specialized products within A&D Pharma Bulgaria. Previously held various positions in BMS (BUH Oncology/Hospital products & Medical Director Bulgaria & Romania) since 1996..
Michal Opuchlik, MDGeneral Manager PolandFormerly Country Manager Alexion Poland, Greece, Cyprus, Israel, Romania and Bulgaria. Prior to that held position of Area General Manager for Poland, Baltic Countries and Russia in AOP Orphan Pharmaceuticals.
Laur Saar, MDCorporate Medical Director,Regulatory & PVUntil May 2015 Medical Director of Valeant / Pharma Swiss Europe since 2006. Prior to that Regional Medical BMS Baltics.
Pavel ChistyakovGeneral Manager Russia andRegional Director EurAsia23+ experience in pharma at executive positions, former General Manager of Ipsen in Russia and CIS (9Y), Pierre Fabre General manager Russia (7Y), Sanofi Trade and Revenue head Russia and EurAsia (5Y) and before joining Swixx Biopharma was Commercial VP for Greece, Russia and Turkey in Italpharmaco..
Benoit ChastaingBoard Member
Marie-Justine LecomteBoard Observer6+ years’ experience in Private Equityand M&A specialized in healthcaretransactions. Former position ininvestment at Gimv
George BithasGeneral Manager Greece,Cyprus and MaltaMore than 20 years experience in pharma industry, holding a series of roles with increasing responsibility in hospital devices, medical nutrition and specialty care in Abbott & AbbVie for Greece and Cyprus. Most recently served as Business Unit Director Immunology.
Petr NěmecFounder, StrategyCo-Founder PharmaSwiss,formerly GM BMS South EastEurope. Previously Sr. ExecutiveConvatec CEE & Lawyerat White & Case
25 years’ experience in M&A transactions and Investment area including operational experiences.10 years of successful private equity investment in the healthcare sector, two main experiences as Manager/Investor under LBO. Former various position at Medipole Partnaires (Elsan) and Senior Healthcare Partner at Gimv
Tomas CernikChief of Staff to CEO,Special Projects Lead andGM Romania & MoldovaFormerly Country Manager of Bristol-Myers Squibb, responsible for Austria, before that for Czech Republic and Hungary. Prior to this held various commercial and finance positions at BMS in different Central European countries